Capitol Clarity / Firms / Jeffrey J. Kimbell & Associates, Inc.

Jeffrey J. Kimbell & Associates, Inc.

Jeffrey J. Kimbell & Associates, Inc. is a registered federal lobbying firm. For Q3 2026 it reported $1.34M across 76 client reports and lists 12 lobbyists across its filings. Issues include Health Issues, Medicare/Medicaid, Trade (domestic/foreign) and Defense.

Clients, Q3 2026

ClientReportedIssues
GILEAD SCIENCES, INC.$75KHealth Issues
NEURALINK CORP.$60KHealth Issues, Medicare/Medicaid
U.S. RENAL CARE$50KMedicare/Medicaid
ASTELLAS PHARMA US$40KHealth Issues
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.$40KHealth Issues
ACCURAY INCORPORATED$40KMedicare/Medicaid, Trade (domestic/foreign)
ARDELYX, INC.$40KHealth Issues, Medicare/Medicaid
BROOKDALE SENIOR LIVING INC.$40KHealth Issues, Housing
GENUS LIFESCIENCES$36KHealth Issues
WE WORK FOR HEALTH$30KMedicare/Medicaid
ORCHARD THERAPEUTICS NORTH AMERICA$30KHealth Issues, Medicare/Medicaid, Pharmacy
LIVANOVA USA INC$30KHealth Issues, Medicare/Medicaid
TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION (FKN TENNESSEE FARM BR. ASSN.)$30KHealth Issues
CATALYST PHARMACEUTICALS$30KHealth Issues
SUPERNUS PHARMACEUTICALS INC$20KHealth Issues, Medicare/Medicaid
KENDAL NUTRICARE LTD$20KAgriculture, Trade (domestic/foreign)
HARROW INC.$20KHealth Issues, Medicare/Medicaid
RECOR MEDICAL$20KHealth Issues, Medicare/Medicaid
INNOVAGE$20KHealth Issues, Medicare/Medicaid
THE ALLERGY & ASTHMA ALLIANCE$20KMedicare/Medicaid
SKY MARKETING CORPORATION$20KAgriculture, Health Issues
COALITION FOR AFFORDABLE PET CARE$20KAnimals, Consumer Issues/Safety/Products, Labor Issues/Antitrust/Workplace
SSI GROUP$20KHealth Issues
TERUMO BCT$20KMedicare/Medicaid, Trade (domestic/foreign)
GLAUKOS CORPORATION (FKA AVEDRO, INC.)$20KHealth Issues, Medicare/Medicaid
HARMONY BIOSCIENCES, LLC$20KHealth Issues
INSTITUTE FOR GENE THERAPIES$20KHealth Issues, Medicare/Medicaid
STERIS CORPORATION$20KHealth Issues
ILLUMINA, INC.$19KBudget/Appropriations, Health Issues
MOMENTOUS$15KDefense
SPARC$15KHealth Issues
SUMMIT BEHAVIORAL HEALTHCARE$15KHealth Issues
PHATHOM PHARMACEUTICALS$15KHealth Issues
ONE CALL, CORP$15KHealth Issues
OPUS GENETICS, INC$15KHealth Issues
GENETIX BIOTHERAPEUTICS$15KHealth Issues
PAR HEALTH USA, LLC$15KHealth Issues, Trade (domestic/foreign)
RAYNER INTRAOCULAR LENSES LIMITED$15KMedicare/Medicaid
ARCUTIS BIOTHERAPEUTICS, INC.$15KHealth Issues
MEDICAL DEVICE MANUFACTURERS ASSOCIATION$10KHealth Issues
PHARMING HEALTHCARE, INC.$10KHealth Issues
COLLEGIUM PHARMACEUTICAL$10KHealth Issues
NEUROTECH PHARMACEUTICALS$10KHealth Issues
INSMED, INC.$10KHealth Issues, Medicare/Medicaid
ALEXION PHARMACEUTICALS$10KHealth Issues, Medicare/Medicaid
CAPRICOR$10KHealth Issues
MOBIA MEDICAL, INC (FKA MICROTRANSPONDER)$10KHealth Issues
JCYTE, INC.$10KHealth Issues
AVALON HEALTHCARE SOLUTIONS$10KHealth Issues
ACME UNITED CORPORATION$10KHealth Issues, Trade (domestic/foreign)
ATEA PHARMACEUTICALS, INC.$10KHealth Issues
NEUSPERA MEDICAL$10KMedicare/Medicaid
AGIOS PHARMACEUTICALS, INC.$10KHealth Issues
INDIVIOR INC.$10KHealth Issues
COLOPLAST CORP$10KMedicare/Medicaid
MAGNUS MEDICAL, INC.$10KHealth Issues, Medicare/Medicaid
MAGNOLIA MEDICAL TECHNOLOGIES, INC.$10KMedicare/Medicaid
INDEMED$10KHealth Issues
ATARA BIOTHERAPEUTICS, INC.$10KHealth Issues
GAURDANT HEALTH$10KHealth Issues
MANNKIND CORPORATION$10KDefense, Health Issues, Medicare/Medicaid
CLEARFLOW, INC.$10KMedicare/Medicaid
PROVERUM MEDICAL$10KHealth Issues
FLEX VASCULAR$10KMedicare/Medicaid
HISTOSONICS, INC$10KHealth Issues, Medicare/Medicaid
CARA MEDICAL$10KHealth Issues, Medicare/Medicaid
GOSSAMER BIO, INC.$10KHealth Issues
ARGENTA US HOLDINGS, INC.$10KAnimals
FLOREO INC.$10KHealth Issues
BIOTISSUE$9KMedicare/Medicaid
AMGEN INC.$8KHealth Issues
ORGANON & CO.$5KHealth Issues, Medicare/Medicaid
HCA MANAGEMENT SERVICES, L.P.$0Health Issues
ARTERA INC.$0
HANSA BIOPHARMA AB$0
IBA PROTON THERAPY$0

By year

YearReportedClients
2026$3.73M84
2025$4.47M70

Lobbyists listed

Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.